Chemical Compound
2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-, 1,1-dioxide; Coxflam; Maxicam; Melonex; Meloxicam; Metacam; Mobec; Mobic; Mobicox; Movalis; Movatec; Revmoksikam; UH-AC 62XX; 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide
CAS Registry Number
71125-38-7
Primary record
2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-, 1,1-dioxide; Coxflam; Maxicam; Melonex; Meloxicam; Metacam; Mobec; Mobic; Mobicox; Movalis; Movatec; Revmoksikam; UH-AC 62XX; 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide
- 库存
- 6,609 克
- 纯度
- 99.2 %
- CAS
- 71125-38-7
化合物标识与属性
- CAS
- 71125-38-7
- PubChem CID
- 54677470
- SMILES
- CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O
- Canonical SMILES
- Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1
名称与同义词
- meloxicam
- Mobic
- Metacam
- 71125-38-7
- Mobicox
- Movalis
- Movatec
- Mobec
- Meloxivet
- Coxicam
- Melfax
- miloxicam
- Meloxicamum
- Meloxidolor
- Meloxoral
- Rheumocam
- Vivlodex
- Melosus
- Meloxicam (Mobic)
- Parocin
- Contacera
- Meloxidyl
- Flexicam
- Inflacam
- Acticam
- Emdocam
- Loxicom
- Melovem
- Recocam
- Tenaron
- RevitaCAM
- reumoxicam
- Revmoksikam
- Coxflam
- Masflex
- Maxicam
- Melonex
- Movicox
- Meloxicamum [Latin]
- Meloxicam sodium
- Alloxate
- Meloxicam-d3
- Ostilox
- Uticox
- Novem
- Ratio-meloxicam
- UH-AC 62XX
- Novo-meloxicam
- Apo-meloxicam
- Dom-meloxicam
- Gen-meloxicam
- Co Meloxicam
- PHL-meloxicam
- PMS-meloxicam
- Movalis;
- Meloxicam 5g
- Meloxicam CRS
- Recoxa;
- Melox;
- Mobic;
- ANJESO
- Meloxicam Injection
- UHAC-62XX
- QMIIZ ODT
- UNII-VG2QF83CGL
- QAMZOVA
- XIFYRM
- VG2QF83CGL
- Meloxicam (Standard)
- Mobic (TN)
- Opera_ID_2
- AC1NTUST
- RefChem:5991
- Metacam Oral Suspension
- Spectrum_001633
- Meloxicam impurity standard
- meloxicam sodium hydrate
- C14H13N3O4S2
- Meloxicam [BAN:INN]
- CHEMBL599
- MELOXICAM [INN]
- MELOXICAM [JAN]
- DTXSID1020803
- MELOXICAM [MI]
- UH-AC-62 XX
- AC1Q3XZW
- MELOXICAM [HSDB]
- MELOXICAM [USAN]
- Spectrum2_000941
- Spectrum3_000649
- Spectrum4_000787
- Spectrum5_001813
- CCRIS 9139
- CHEBI:6741
- MELOXICAM [VANDF]
- D0G7FJ
- DTXCID70803
- Epitope ID:613442
- MELOXICAM [MART.]
- AC1L1HB1
- AC1NQY12
- MELOXICAM [USP-RS]
- MELOXICAM [WHO-DD]
- MLS000028587
- SCHEMBL3576
- ZRVUJXDFFKFLMG-UHFFFAOYSA-N
- Boc-L-3-Benzothienylalanine
- Meloxicam (JAN/USP/INN)
- Lopac0_000766
- MFCD00868752
- SCHEMBL33369
- BSPBio_002257
- KBioGR_001234
- KBioSS_002113
- HSDB 7741
- Meloxicam [USAN:BAN:INN]
- Meloxicam [USAN:INN:BAN]
- MLS001304725
- MLS001306413
- MLS006011422
- BIDD:GT0726
- SCHEMBL713100
- SPECTRUM1504150
- Meloxicam - Bio-X trade mark
- SPBio_000902
- MELOXICAM [GREEN BOOK]
- Meloxicam [USAN:USP:INN:BAN]
- ZELERIS COMPONENT MELOXICAM
- GTPL7220
- orb1310257
- OroCAM Transmucosal Oral Spray
- SYMBRAVO COMPONENT MELOXICAM
- ZYNRELEF COMPONENT MELOXICAM
- MELOXICAM [ORANGE BOOK]
- CHEMBL1741042
- MELOXICAM [EP MONOGRAPH]
- Meloxicam Solution for Injection
- SCHEMBL23589638
- 4-Hydroxy-2-methyl-N-(5-methylthiazol-2-yl)-2H-benzo[e][1,2]thiazine-3-carboxamide 1,1-dioxide
- CTK6C3599
- CTK6C3600
- HY-B0261R
- KBio2_002113
- KBio2_004681
- KBio2_007249
- KBio3_001477
- Meloxicam (SoluMatrix/arthritis)
- CID4052
- ETI-511
- M01AC06
- MELOXICAM [USP MONOGRAPH]
- MSK7155
- s1734
- GLXC-07998
- HMS1922D19
- HMS2089B18
- HMS2096I19
- HMS2234P07
- HMS2236C09
- HMS3259H06
- HMS3372C13
- HMS3372P18
- HMS3655K06
- HMS3713I19
- HMS3744K09
- HMS3884G08
- HMS5079D20
- ALBB-027268
- AMY40407
- BCP11928
- HY-B0261
- KS-00000JN4
- 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
- Tox21_111734
- Tox21_113192
- Tox21_201689
- Tox21_302756
- ANW-57553
- BBL029076
- BDBM50056998
- CCG-39098
- EBC-12958
- HSCI1_000045
- MSK7155-100A
- N-1539
- NCGC00018248-04
- STK620505
- ZINC13129998
- Meloxicam - CAS 71125-38-7
- Meloxicam 100 microg/mL in Acetonitrile
- N1539
- SMR000058994
- AKOS000279442
- AKOS026749959
- Tox21_111734_1
- ZINC103620661
- AC-1325
- ACN-048198
- C14-H13-N3-O4-S2
- CID5281106
- CID5388987
- CS-2247
- DB00814
- FH25045
- KS-1084
- MELOXICAM [EMA EPAR VETERINARY]
- NC00698
- RTR-031220
- CID-2950007
- Metacam 5 mg/mL Solution for Injection
- SMP2_000133
- NCGC00018248-01
- NCGC00018248-02
- NCGC00018248-03
- NCGC00018248-05
- NCGC00018248-06
- NCGC00018248-07
- NCGC00018248-08
- NCGC00018248-10
- NCGC00018248-23
- NCGC00018248-24
- NCGC00018248-25
- NCGC00018248-26
- NCGC00022924-03
- NCGC00022924-04
- NCGC00159516-02
- NCGC00256316-01
- NCGC00259238-01
- NCGC00263878-02
- AJ-63405
- AK-77454
- AN-15016
- BC200593
- BH164661
- CID:54677470
- CPD000718800
- LS-40538
- SAM002589991
- SC-12165
- SMR000718800
- 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
- Meloxicam (SoluMatrix/arthritis), iCeutica
- Meloxicam 1000 microg/mL in Acetonitrile
- SID:376229702
- AB0007297
- AB1009494
- CAS-71125-38-7
- DB-055490
- Meloxicam 1.0 mg/ml in Dimethyl Sulfoxide
- TL8005001
- A8466
- FT-0628193
- M1959
- NS00000018
- R3928
- ST24023559
- SW219562-1
- EN300-52507
- Meloxicam Solution in Acetonitrile, 100ug/mL
- A10565
- C08169
- D00969
- F20356
- J10218
- M02128
- AB00383033-17
- AB00383033-18
- AB00383033_20
- 125M387
- A837087
- AN-668/13244001
- C065757
- Q414028
- SR-01000003132
- I06-0490
- 2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-, 1,1-dioxide
- 4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide
- SR-01000003132-10
- D000077239
- F2173-0387
- Meloxicam nanoformulation capsules (arthritis), iCeutica
- Meloxicam, 99%, a selective COX inhibitor - 25G 25g
- Z1695493323
- 2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-(5-methylthiazolyl)-, 1,1-dioxide
- Meloxicam Working Standard (Secondary Reference Standard)
- 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1lambda6,2-benzothiazine-3-carboxamide
- 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-2H-1$l^{6},2-benzothiazine-3-carboxamide
- 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazoyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide
- (3E)-3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one
- 2H-1,2-Benzothiazine-3-carboximidic acid, 4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-, 1,1-dioxide
- 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1|E6,2-benzothiazine-3-carboxamide
- (3E)-3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1
- (3Z)-3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1
- 3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1
- 4-hydroxy-2-methyl-N-(5-methy-2-thiazolyl)-2H-1,2-benzothiazine-3-caboxamide-1,1-dioxide
- (E)-3-(hydroxy((5-methylthiazol-2-yl)amino)methylene)-2-methyl-2,3-dihydro-4H-benzo[e][1,2]thiazin-4-one 1,1-dioxide
- 2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-, 1,1-dioxide; Coxflam; Maxicam; Melonex; Meloxicam; Metacam; Mobec; Mobic; Mobicox; Movalis; Movatec; Revmoksikam; UH-AC 62XX; 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide
- 3-[hydroxy-[(5-methylthiazol-2-yl)amino]methylene]-2-methyl-1,1-dioxo-1$l^{6},2-benzothiazin-4-one
- 3-{hydroxy[(5-methyl-1,3-thiazol-2-yl)amino]methylidene}-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide
- 3-{hydroxy[(5-methyl-1,3-thiazol-2-yl)amino]methylidene}-2-methyl-3,4-dihydro-2H-1lambda6,2-benzothiazine-1,1,4-trione
- 4-Hydroxy-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[e][1,2]thiazine-3-carboxylic acid (5-methyl-thiazol-2-yl)-amide
- 4-hydroxy-2-mehtyl-N-(5-mehtyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
- 4-Hydroxy-2-methyl-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[e][1,2]thiazine-3-carboxylic acid (5-methyl-thiazol-2-yl)-amide
- 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1$l^(6),2-benzothiazine-3-carboxamide
- 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1$l^{6},2-benzothiazine-3-carboxamide
- 4-Hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1,2-dihydro-1lambda~6~,2-benzothiazine-3-carboxamide
- 4-Hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1lambda{6},2-benzothiazine-3-carboxamide
- 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-2H-1$l^(6),2-benzothiazine-3-carboxamide
- 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-2H-1lambda6,2-benzothiazine-3-carboxamide
- 4-Hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazin-3-crboxamide 1,1-dioxide
- 4-hydroxy-2-methyl-N-(5-methyl-2-thiazole)-2H-1,2-benzothiazine-3 -carboxamide 1,1-dioxide
- 4-hydroxy-2-methyl-N-(5-methylthiazol-2-yl)-1,1-dioxo-1lambda6,2-benzothiazine-3-carboxamide
- 4-Hydroxy-2-methyl-N-(5-methylthiazol-2-yl)-2H-benzo[e][1,2]thiazine-3-carboxamide1,1-dioxide
- 4-hydroxy-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-2-(trideuteriomethyl)-1lambda6,2-benzothiazine-3-carboxamide
- 615-253-8
- 942047-63-4
- MXM